This site is intended for healthcare professionals only

Diabetes Digest


Share this article

Factors associated with successful islet cell transplantation

Four factors, mostly controllable and achievable with current practices, are associated with favourable outcomes.

This prospective, observational analysis sought to determine the factors associated with favourable outcomes of islet cell transplantation. A total of 398 people with type 1 diabetes who were C-peptide-negative and underwent islet transplantation were followed up >1 year and up to 10 years after transplantation. People who underwent islet-after-kidney or simultaneous-islet/kidney transplantation were excluded; this analysis was limited to those who underwent islet cell transplantation alone (for whom the benefits of islet cell transplantation need to be weight against the risks associated with immunosuppression).

Six outcomes (including various HbA1c, fasting glucose and C-peptide levels, absence of severe hypoglycaemia and exogenous insulin independence) were used to define successful transplantation. Analysis revealed that, perhaps surprisingly, only four clinical factors were strong predictors of all six favourable outcomes. These were:

  • Recipient age ≥35 years.
  • A total of ≥325 000 islet cell equivalents infused over one or more infusions.
  • Administration of T-cell-depleting antibodies and/or TNF-α inhibition from first transplant.
  • Maintenance with calcineurin inhibitors (CNI) and mTOR inhibitors for at least some portion of follow-up.

At 5 years after the last islet infusion, of the recipients who met these four common factors (N=126), 95% were free of severe hypoglycaemia, 76% had an HbA1c <53 mmol/mol and 53% were insulin-independent, significantly higher rates than were seen in participants who did meet all four factors (N=272). The rate of serious adverse events due to the procedure or immunosuppression was low (around 0.06 events per person) in both groups.

The authors point out that these four factors are few and, with the exception of age, controllable and achievable with current practices. Furthermore, even in younger people, the positive outcome rates were only around 5% lower if all three other factors were met. Therefore, age alone should not be considered a disqualifying factor for islet cell transplantation.

The authors conclude that these findings provide important new insights to guide transplant centres in developing and refining islet cell transplant protocols.

Click here to read the study in full.

Related content
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals


By clicking ‘Subscribe’, you are agreeing that are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.